🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In Phase I, This study will explore the tolerability and safety of RC118 in...
Status
Recruiting
Location
Zhongshan Hospital Affiliated to Fudan University
Start Date
2022-03-03
Trial ID
NCT05205850
Treatments Being Tested
This is a single-arm, multicenter, phase II study designed to evaluate the ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-10
Trial ID
NCT07542717
Treatments Being Tested
The objective of this study is to assess the safety, efficacy, pharmacokine...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2022-01-19
Trial ID
NCT05141747
Treatments Being Tested
This is a multicenter, two-arm, exploratory clinical study designed to eval...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-05
Trial ID
NCT07528898
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Start Date
2023-03-20
Trial ID
NCT05798156
Treatments Being Tested
This study is to define the safety profile and to determine the Maximal tol...
Status
Terminated
Location
Mayo Clinic
Start Date
2017-04-24
Trial ID
NCT02908451
Treatments Being Tested
Phase 1/2 trial to study the safety, pharmacokinetics and preliminary effic...
Status
Terminated
Location
The first affiliated hospital, Zhejiang Unviersity school of medicine
Start Date
2022-11-25
Trial ID
NCT05611853
Treatments Being Tested
HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which spec...
Status
Recruiting
Location
The Second Affiliated Hospital Zhejiang University
Start Date
2024-10-03
Trial ID
NCT06825624
Treatments Being Tested
This is an open-label, single-arm, Phase II investigator-initiated trial of...
Status
Unknown
Location
The First Bethune Hospital of Jilin University
Start Date
2021-11-01
Trial ID
NCT05115500
Treatments Being Tested